-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Regulatory Stringency
New Cancer Drugs Often Bestow Little Benefit Regarding Survival or Wellbeing? (NHS Choices / BMJ)
Summary A quotation from the authors’ abstract may say it all: “This systematic evaluation of oncology approvals by the European Medicines Agency (EMA) in 2009-13 shows that most drugs entered the market without evidence of benefit on survival or quality … Continue reading
Posted in Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, International, Management of Condition, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Statistics, Systematic Reviews, UK, Universal Interest
Tagged Advanced Melanoma: Improving Survival Rates, Assessment of Quality of Life, Bazian, Behind the Headlines, Better Regulation, Big Pharma, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Cancer, Cancer Drugs Approved by EMA (2009-13), Cancer Drugs Approved on Basis of Surrogate End Points, Cancer Drugs Fund (CDF), Cancer Pharmaceuticals (New Approvals), Cancer Research, Cancer Survival, Cancer Survival Group: London School of Hygiene and Tropical Medicine, Cancer Treatment (Newer Drugs), Combination Nivolumab Plus Ipilimumab, Department of Global Health and Social Medicine: King's College London, Department of Health Policy: London School of Economics and Political Science, Department of Health Services Research and Policy: London School of Hygiene and Tropical Medicine, Drug Regulation, EMA: European Medicines Agency, European Medicines Agency, European Medicines Agency (Cancer Drug Approvals), European Medicines Agency (EMA), European Public Assessment Reports (EPARs), European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS), European Society for Medical Oncology's Magnitude of Clinical Benefit Scale (MCBS), Evidence Versus Mythology, Faculty of Pharmacy: Riga Stradins University, Institute of Cancer Policy: King's College London, Kings College London, Latvia, London, London School of Economics and Political Science, London School of Hygiene and Tropical Medicine, London School of Hygiene and Tropical Medicine (LSHTM), LSE Health: London School of Economics and Political Science, LSHTM: London School of Hygiene and Tropical Medicine, Market Approval (New Cancer Drugs), Myth-Busting, Myths and Misconceptions About New Cancer Drugs, New Cancer Drug Approvals (EMA), Pharmaceutical Industry, Pharmaceutical Regulators, Pharmaceuticals, Quality of Life, Regulatory Experts, Regulatory Requirements, Regulatory Stringency, Regulatory System, Riga Stradins University (Latvia), Skin Cancer, Surrogate End Points Versus Subsequent Efficacy / Survival, Thinking Like a Patient and Acting Like a Taxpayer
Leave a comment
Professional Standards Authority Report on NMC (BBC News / Department of Health)
Summary The Nursing and Midwifery Council has been criticised by the Professional Standards Authority over its handling of disciplinary cases. Full Text Link Reference Hughes, D. (2014). Mid-Staffs scandal: Nursing and Midwifery Council criticised. London: BBC Health News, March 31st … Continue reading
Posted in BBC News, Department of Health, For Carers (mostly), For Nurses and Therapists (mostly), In the News, National, NHS, Quick Insights, Standards, UK, Universal Interest
Tagged 2013 Accountability Hearing with the Nursing and Midwifery Council (NMC), Accountability, BBC Health News, Commons Health Select Committee, Fitness-to-Practise (FtP), Hearing Cases, House of Commons Health Committee, House of Commons Health Committee Report on the NMC, House of Commons Health Select Committee (HSC), Implications of the Francis Inquiry Report, Mid-Staffordshire NHS Trust, Mutual Recognition of Professional Qualifications (MRPQ), Mutual Recognition of Professional Qualifications (MRPQ) Directive, Nursing and Midwifery Council (NMC), Parliament, Patients First and Foremost, Processing Hearing Cases, Professional Regulation, Professional Standards, Professional Standards Authority, Professional Standards Authority: Formerly the Council for Healthcare Regulatory Excellence (CHRE), Professionalism, Putting Patients First, Record-Keeping, Regulation, Regulators, Regulatory Stringency, Repercussions From the Francis Inquiry Report, Transparency and Accountability, UK Parliament
Leave a comment
Keogh Review Visits for Lowest Performing 14 “Mortality Outlier” Hospitals (NHS England)
Summary Experienced teams of doctors, nurses and patient representatives are to visit 14 hospital trusts where mortality ratios have shown higher-than-expected rates for the past two years. as part of NHS England‘s Keogh review. “…intelligence held by different organisations across the NHS … Continue reading
Posted in Acute Hospitals, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Local Interest, National, NHS, NHS England, Quick Insights, Standards, UK, Universal Interest
Tagged Acute Care, Acute Hospital Care, Acute Hospitals, Basildon and Thurrock University Hospitals NHS Foundation Trust, Blackpool Teaching Hospitals NHS Foundation Trust, Buckinghamshire Healthcare NHS Trust, Burton Hospitals NHS Foundation Trust, Care in General Hospitals, Chief Inspector of Hospitals, Colchester Hospital University NHS Foundation Trust, Consequences of the Francis Inquiry Report, Dementia Care in Acute General Hospitals, Dementia Care in Acute Settings, Dementia Care in General Hospitals, Dudley Group NHS Foundation Trust, East Lancashire Hospitals NHS Trust, Francis Inquiry, General Hospitals, Generalised Hospital Mortality, George Eliot Hospital NHS Trust, Hospital Inspections, Hospital Mortality, Hospital Mortality Rates, Hospital Standardised Mortality Ratios (HSMRs), Implications of the Francis Inquiry Report, Keogh Mortality Review, Keogh Review, Medical Director of NHS England: Professor Sir Bruce Keogh, Medway NHS Foundation Trust, Mid-Staffordshire NHS Trust, Mortality, Mortality Outlier Hospitals, Mortality Rates, NHS England (Formerly the NHS Commissioning Board), North Cumbria University Hospitals NHS Trust, Northern Lincolnshire and Goole Hospitals NHS Foundation Trust, Outlier Hospitals, Patient Experience, Patient Safety, Preventable Hospital Mortality, QSGs: Quality Surveillance Groups, Quality Surveillance Groups, Quality Surveillance Groups (QSGs), Rapid Responsive Review Teams, Rapid Responsive Reviews, Regional Medical and Nursing Directors of NHS England, Regulation, Regulatory Stringency, Risk Summits, Sherwood Forest Hospitals NHS Foundation Trust, Sir Bruce Keogh (Former Chief Executive of the NHS Commissioning Board; now NHS England), Tameside Hospital NHS Foundation Trust, United Lincolnshire Hospitals NHS Trust
Leave a comment
Care Quality Commission Strategy for 2013 to 2016 (CQC)
Summary This Care Quality Commission (CQC) strategy document outlines how the CQC proposes to inspect and regulate services to ensure people receive safe, effective, compassionate and high-quality care. Section headings in this report comprise: CQC purpose, role and principles. CQC plans for … Continue reading
Posted in Acute Hospitals, Community Care, CQC: Care Quality Commission, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), National, Patient Care Pathway, Person-Centred Care, Quick Insights, Standards, UK, Universal Interest
Tagged Care Home Inspections, Care Home Regulation, Care Quality Commission (CQC), Care Quality Commission Strategy for 2013 to 2016, Care Transitions, Care Transitions of Older People, Chief Inspector of Hospitals, Chief Inspector of Primary and Integrated Care, Chief Inspector of Primary Care (Exploratory), Chief Inspector of Social Care, Chief Inspector of Social Care and Support, Deprivation of Liberty, Deprivation of Liberty Safeguards (DoLS), Dignity and Nutrition Inspection Programme (DANI), Diversity, Elderly Human Rights, Equality, Expert Inspectors, Experts by Experience, Hospital Inspections, Human Rights, Human Rights and Nursing, Human Rights in Care Homes, Independent Chief Inspector of Hospitals, Mental Health Act 1983, Mental Health Act 2007, Optional Protocol to the Convention against Torture (OPCAT), Patient Experience, Point of Care: Improving Patient Experience, Putting People First, Raising Standards: Putting People First (CQC), Regulation, Regulatory Stringency, Social Care Market Regulation, United Nations Optional Protocol to the Convention Against Torture (OPCAT)
Leave a comment
Antipsychotic Prescribing in Nursing Homes in the United States: Response to Regulatory Stringency (Health Economics)
Summary This paper studies the impact of regulatory stringency in the USA (as measured by the statewide deficiency citation rate over the past year) on the quality of care provided in a US national sample of nursing homes from 2000 … Continue reading
Posted in Antipsychotics, For Researchers (mostly), International, Pharmacological Treatments, Quick Insights
Tagged Antipsychotic Drugs, Antipsychotic Prescribing in Nursing Homes in the United States, Antipsychotics, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Department of Economics and Scripps Gerontology Center: Miami University, Farmer School of Business: Miami University, Health Economics, Inappropriate Prescribing, Nursing Homes, Nursing Homes in the United States, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Regulatory Stringency, United States
Leave a comment
